Form D Explorer
Gut-Brain-Axis Therapeutics Inc. · CIK 1996678

Report a data issueCitable research briefCompare issuerPrivate research collection

Gut-Brain-Axis Therapeutics Inc.

CIK 1996678 · Corporation · Inc. DELAWARE · TEMPE, Arizona · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Nov 6, 2025
through Oct 27, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldNov 6, 2025 · DOct 27, 2026 · D/ALater minus earlier
Reported offering amount$20,000,000$20,000,000$0
Reported amount sold$1,965,000$1,965,000$0
Reported investor count—22—
Reported minimum investment$0$0$0

Earlier SEC source: 0001996678-25-000002 · Later SEC source: 0001996678-26-000001

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 27, 2026

Reported offering amount
$20,000,000
Reported exemptions
Rule 506(c)
Reported amount sold
$1,965,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (2)